THE EFFECTS OF HPV VACCİNATİON AND MESSAGE FRAMİNG
THE EFFECT OF GAIN AND LOSS FRAMING MESSAGES ON RISK PERCEPTION AND KNOWLEDGE LEVELS REGARDING HPV VACCINATION AMONG UNIVERSITY STUDENTS: A RANDOMIZED CONTROLLED TRIAL
Background: University students are at high risk for HPV infection, while HPV vaccination rates remain low. Message framing strategies may influence vaccination-related perceptions and intentions.
Objective: This study aims to compare the effects of gain- and loss-framed HPV vaccination messages on HPV risk perception, HPV knowledge, and vaccination intention among university students.
Methods: This randomized controlled experimental study includes university students from the health sciences faculty of a foundation university. Participants are assigned to gain-framed, loss-framed, and control groups. Data are collected using the Human Papillomavirus Knowledge Scale and the HPV Risk Perception Questionnaire. Statistical analyses include one-way ANOVA, two-way ANOVA, and Chi-square tests. The study is designed in accordance with CONSORT 2010 and EQUATOR Network reporting guidelines.
Keywords: message framing; gain-loss framing; human papillomavirus; vaccination
研究概览
地位
详细说明
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Ankara
-
Ankara、Ankara、土耳其（türkiye）、06000
- Ankara Medipol Üniversitesi
-
-
参与标准
资格标准
适合学习的年龄
- 成人
接受健康志愿者
描述
Inclusion Criteria:
- Aged 18 years or older
- Voluntarily agrees to participate in the study
- Has not received formal education about HPV through a course or class
Exclusion Criteria:
- Has received the HPV vaccine
- Has participated in formal education about HPV through a course or class
- Has a current or previous positive HPV test result or HPV diagnosis
学习计划
研究是如何设计的？
设计细节
- 主要用途：预防
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Gain-Framed Group
Participants received gain-framed HPV vaccination messages.
|
Participants received gain-framed messages emphasizing the benefits of HPV vaccination.
|
|
实验性的：Loss-Framed Group
Participants received loss-framed HPV vaccination messages.
|
Participants received loss-framed messages emphasizing the consequences of not receiving HPV vaccination.
|
|
无干预：Control Group
Participants did not receive framed HPV vaccination messages.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
HPV vaccination intention
大体时间：Immediately after message exposure
|
Participant intention to receive the HPV vaccine measured immediately after message exposure using a self-reported vaccination intention scale.
|
Immediately after message exposure
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- AMU-EBE-2025-173 (其他标识符：Ankara Medipol University Clinical Research Ethics Committee)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.